PLAINTIFFS' BAYCOL STEERING COMMITTEE, KENNETH B. MOLL KENNETH B. MOLL & ASSOCIATES, LTD. v. BAYER CORPORATION BAYER AG GLAXOSMITHKLINE, — PLAINTIFFS' BAYCOL STEERING COMMITTEE, K. AMY LEMON v. BAYER CORPORATION BAYER AG GLAXOSMITHKLINE

419 F.3d 794, 2005 U.S. App. LEXIS 17577
CourtCourt of Appeals for the Eighth Circuit
DecidedAugust 19, 2005
Docket04-2097
StatusPublished

This text of 419 F.3d 794 (PLAINTIFFS' BAYCOL STEERING COMMITTEE, KENNETH B. MOLL KENNETH B. MOLL & ASSOCIATES, LTD. v. BAYER CORPORATION BAYER AG GLAXOSMITHKLINE, — PLAINTIFFS' BAYCOL STEERING COMMITTEE, K. AMY LEMON v. BAYER CORPORATION BAYER AG GLAXOSMITHKLINE) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
PLAINTIFFS' BAYCOL STEERING COMMITTEE, KENNETH B. MOLL KENNETH B. MOLL & ASSOCIATES, LTD. v. BAYER CORPORATION BAYER AG GLAXOSMITHKLINE, — PLAINTIFFS' BAYCOL STEERING COMMITTEE, K. AMY LEMON v. BAYER CORPORATION BAYER AG GLAXOSMITHKLINE, 419 F.3d 794, 2005 U.S. App. LEXIS 17577 (8th Cir. 2005).

Opinion

419 F.3d 794

PLAINTIFFS' BAYCOL STEERING COMMITTEE, Plaintiff,
Kenneth B. Moll; Kenneth B. Moll & Associates, Ltd., Appellants,
v.
BAYER CORPORATION; Bayer AG; GlaxoSmithKline, Defendants — Appellees.
Plaintiffs' Baycol Steering Committee, Plaintiff,
K. Amy Lemon, Appellant,
v.
Bayer Corporation; Bayer AG; GlaxoSmithKline, Defendants-Appellees.

No. 04-2097.

No. 04-2187.

United States Court of Appeals, Eighth Circuit.

Submitted: February 17, 2005.

Filed: August 19, 2005.

COPYRIGHT MATERIAL OMITTED COPYRIGHT MATERIAL OMITTED Eric John Magnuson, argued, Minneapolis, MN, for appellant Moll.

John Michael Degnan, argued, Minneapolis, MN, for appellant Lemon.

Adam L. Hoeflich, argued, Chicago, IL, for appellee.

Before BYE, HEANEY, and MELLOY, Circuit Judges.

BYE, Circuit Judge.

Kenneth B. Moll, and his firm Kenneth B. Moll & Associates Ltd. (KBM), and K. Amy Lemon, appeal the district court's order imposing sanctions against them for their conduct in the Baycol Multi-District Litigation (MDL). Pursuant to its inherent power, the district court removed Moll and KBM from the plaintiffs' steering committee (PSC) and imposed a $50,000 sanction against Moll after finding Moll committed perjury, violated two pretrial orders, and violated multiple provisions of the Minnesota Rules of Professional Conduct. Additionally, the district court sua sponte barred Lemon from the practice of law in the United States District Court for the District of Minnesota after finding she committed perjury and violated provisions of the Minnesota Rules of Professional Conduct. We affirm the removal of Moll and KBM from the PSC, but vacate the $50,000 sanction imposed against Moll and remand for further proceedings. We reverse the district court's imposition of sanctions against Lemon.

I. Background

The Baycol product liability litigation concerns a medication known as Baycol, which was used to lower cholesterol before it was withdrawn from the market in August 2001. On December 18, 2001, the judicial panel on multidistrict litigation established the Baycol MDL, in which Bayer Corporation, Bayer A.G., and GlaxoSmithKline are defendants. All federal district court Baycol cases were transferred to the District of Minnesota. The PSC is a select group of lawyers charged with coordinating and directing pretrial proceedings on behalf of plaintiffs in the Baycol MDL. The district court appointed Moll and KBM to serve as one of the eighteen members of the PSC and one of the seven attorneys on the PSC's executive committee.

Pre-Trial Order (PTO) 18 directs all filings in the Baycol MDL "shall be filed and served through Verilaw Technologies," a provider of electronic document storage and management services. The order states documents filed through Verilaw "shall not be filed by traditional paper means" and "will not contain visual representations of the filing attorneys' signatures." Instead, PTO 18 provides:

On word processing files that they submit, attorneys shall, in place of a signature and where the signature would normally appear, place "Original Signature on File with Filing Attorney." A Filing Attorney shall make an original signature available to any registered user upon request. The filer of any document requiring multiple signatures . . . must list thereon all the names of other signatories by means of an "/s/____" block for each. By submitting such a document, the filer certifies that each of the other signatories has expressly agreed to the form and substance of the document and the filer has their actual authority to submit the document electronically. The filer must maintain any records evidencing this concurrence for subsequent production to the Court if so ordered or for inspection upon request by a party.

PTO 24 provides confidential documents produced in the Baycol MDL "shall not be disclosed to anyone other than" the court, the parties to the litigation, the parties' counsel, and certain outside experts and consultants. PTO 24 further states "[a]ll parties and their respective counsel . . . shall take all steps reasonably necessary to prevent the disclosure of confidential discovery material other than in accordance with the terms of this Order." The order also states unauthorized disclosure "may subject the disclosing person to such sanctions and remedies as the Court may deem appropriate."

In August 2002, at the PSC's request, Moll, who speaks Italian, scheduled a meeting with Raffaelle Guariniello, an Italian prosecutor, to discuss the criminal investigation of Bayer A.G. managers in Europe and to review related documents. In October 2002, Moll met with Guariniello in Torino, Italy. According to Moll, at this meeting he provided Guariniello with non-privileged documents and he promised to file a motion to intervene, which would allow Guariniello access to privileged documents.

The October 2002 meeting included a teleconference with members of the PSC who were in the United States. During the teleconference, the PSC members in the United States were told to "gather as many documents as [they could] or any documents [they] felt were not privileged" for Guariniello to review. Following the teleconference, Ron Goldser sent an email to Guariniello's account and attached two documents: a PowerPoint presentation entitled "Baycol Hot Documents Seminar," and a document entitled "Baycol-MDL 1431 Liability Summary." These documents were created by the PSC and contained portions of Bayer's confidential documents. Moll was copied in the email. In the email, Goldser instructed Guariniello to let Moll review the attached documents for confidentiality before viewing them. Guariniello did not read Goldser's message before opening the attachments, and Moll did not read the email until after Guariniello viewed the documents. Moll viewed the PowerPoint attachment with Guariniello. Every page of both documents contained the following: "CONFIDENTIAL — SUBJECT TO PROTECTIVE ORDER."

On October 21, 2002, after returning from Italy, Moll received an email from Guariniello's assistant, Patrizia Solia, asking Moll if he had any news regarding Guariniello's access to privileged documents. In December 2002, Moll and KBM associate Hal Kleinman exchanged emails with Solia regarding information KBM needed to prepare a motion to intervene. On January 20, 2003, Kleinman sent an email to Solia and Guariniello in which he stated he was working on a final draft of the motion to intervene and requested additional information. Solia responded to Kleinman the same day and thanked Kleinman for "helping us to receive Baycol documents." In January and February 2003, Kleinman and Solia exchanged more emails regarding the motion. In a February 27, 2003, email, Solia asked Kleinman: "How is going your Motion for Permission to provide us copies of Bayer documentation?" After March 5, 2003, however, there is no evidence of communication between Guariniello's office and KBM until June 2003.

Lemon graduated from law school in 2002 and was admitted to the Illinois and Indiana state bars. After working for a medical malpractice firm for less than a year, she joined KBM in Chicago. Lemon started with KBM the last week of May 2003.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Crowe v. Smith
151 F.3d 217 (Fifth Circuit, 1998)
The United States v. Hudson and Goodwin
11 U.S. 32 (Supreme Court, 1812)
Ex Parte Burr
22 U.S. 529 (Supreme Court, 1824)
United States v. Norris
300 U.S. 564 (Supreme Court, 1937)
United States v. Debrow
346 U.S. 374 (Supreme Court, 1953)
Link v. Wabash Railroad
370 U.S. 626 (Supreme Court, 1962)
Cooter & Gell v. Hartmarx Corp.
496 U.S. 384 (Supreme Court, 1990)
Chambers v. Nasco, Inc.
501 U.S. 32 (Supreme Court, 1991)
United States v. Dunnigan
507 U.S. 87 (Supreme Court, 1993)
Marlyn S. Jensen v. Federal Land Bank of Omaha
882 F.2d 340 (Eighth Circuit, 1989)
In Re: Clara Clark
223 F.3d 859 (Eighth Circuit, 2000)
Gardenia Gordon v. Unifund Ccr Partners
345 F.3d 1028 (Eighth Circuit, 2003)
Plaintiffs' Baycol Steering Committee v. Bayer Corp.
419 F.3d 794 (Eighth Circuit, 2005)
United States v. Gonzalez-Lopez
403 F.3d 558 (Eighth Circuit, 2005)
Harlan v. Lewis
982 F.2d 1255 (Eighth Circuit, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
419 F.3d 794, 2005 U.S. App. LEXIS 17577, Counsel Stack Legal Research, https://law.counselstack.com/opinion/plaintiffs-baycol-steering-committee-kenneth-b-moll-kenneth-b-moll-ca8-2005.